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OBJECTIVES We sought to evaluate the long-term impact of cardiac resynchronization therapy (CRT) on
left ventricular (LV) performance and remodeling using three-dimensional echocardiography
and tissue Doppler imaging (TDI).
BACKGROUND Three-dimensional echocardiography and TDI allow rapid and accurate evaluation of LV
volumes and performance.
METHODS Twenty-five consecutive patients with severe heart failure and bundle branch block who
underwent biventricular pacemaker implantation were included. Before and after implanta-
tion of the pacemaker, three-dimensional echocardiography and TDI were performed. These
examinations were repeated at outpatient visits every six months.
RESULTS Five patients (20%) died during one-year follow-up. In the remaining 20 patients, significant
reductions in LV end-diastolic volume and LV end-systolic volume of 9.6  14% and 16.5
 15%, respectively (p  0.01), could be demonstrated during long-term follow-up.
Accordingly, LV ejection fraction increased by 21.7  18% (p  0.01). According to a
newly developed TDI technique—tissue tracking—all regional myocardial segments
improved their longitudinal systolic shortening (p  0.01). The extent of the LV base
displaying delayed longitudinal contraction, as detected by TDI before pacemaker
implantation, predicted long-term efficacy of CRT. The QRS duration failed to predict
resynchronization efficacy.
CONCLUSIONS Cardiac resynchronization significantly improved LV function and reversed LV remodeling
during long-term follow-up. Patients likely to benefit from CRT can be identified by TDI
before implantation of a biventricular pacemaker. (J Am Coll Cardiol 2002;40:723–30)
© 2002 by the American College of Cardiology Foundation
According to the findings at cardiac catheterization, cardiac
resynchronization therapy (CRT) by biventricular pacing
acutely improves left ventricular (LV) function in patients
with severe heart failure and bundle branch block (1,2).
Reports on the use of noninvasive techniques for the short-
and long-term evaluation of CRT efficacy are limited thus
far (3–5). However, radioisotope techniques have a low
temporal and spatial resolution, making them less suitable
to quantify regional LV synchrony. Recently introduced
echocardiographic techniques, such as tissue Doppler imag-
ing (TDI) and three-dimensional echocardiography, enable
accurate quantification of regional and global LV function
and volumes (6–10). From digitally recorded TDI loops of
one or more heart beats containing velocity data from the
entire myocardium, two new TDI modalities can be derived:
tissue tracking (TT) and strain rate (SR) analysis (11).
Tissue tracking visualizes the longitudinal motion ampli-
tude in each myocardial segment during systole (Figs. 1 and
2), and SR analysis can be used to determine whether this
motion represents contraction or is merely passive (Fig. 3).
We found TT and SR useful for the evaluation of regional
myocardial pathophysiology before and after cardiac resyn-
chronization and, therefore included TT and SR analysis in
our follow-up study.
Using TDI and three-dimensional echocardiography
(5,6), we have recently reported on the immediate benefit of
CRT in terms of myocardial synchrony and performance,
resulting in the early reduction in operating LV volumes (5).
We also quantitated the degree of LV mechanical asyn-
chrony by the extent of myocardium at the LV base
displaying delayed longitudinal contraction (DLC) (i.e.,
contraction after closure of the aortic valve). Using multi-
variate analysis, we found that the number of segments with
DLC (at the LV base) was the only co-variate to predict
short-term CRT efficacy (5).
At present, the long-term efficacy of CRT in terms of LV
performance is poorly elucidated. Because of the observed
short-term effect on LV function and volumes, we hypoth-
esized that long-term therapy would further improve LV
systolic performance and reverse LV remodeling. These
aspects, as well as potential predictors of long-term CRT
benefit, are addressed in the present report.
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METHODS
Patient group. The patient group comprised 25 consecu-
tive patients included in a recently published study on the
short-term effect of CRT (5). Despite receiving stable (6
months), contemporary medication for heart failure, all
patients were in New York Heart Association (NYHA)
functional class III or IV. All were in sinus rhythm and had
bundle branch block with a QRS width above 120 ms.
Implantation technique. Pacemaker leads were inserted
by the transvenous route. Three pacing leads were im-
planted: one in the right atrium, another in the high septum
or outflow tract of the right ventricle (RV) and one in the
coronary sinus (Medtronic 2187 or 10512, Minneapolis,
Minnesota); this last lead was positioned on the LV free
wall through a coronary sinus tributary. The RV and LV
pacing leads were positioned to ensure that the sensed local
intracardiac activation during sinus rhythm was measured as
early for the RV lead and as late for the LV lead as possible,
according to the QRS complex on the surface electrocar-
diogram. The pacing leads were connected to a dual-
chamber biventricular pacemaker (Medtronic, InSync), with
nonprogrammable simultaneous pacing of the two ventric-
ular leads. The biventricular pacemaker was programmed in
DDD mode. Adjustment of the atrioventricular delay was
performed to ensure the longest possible atrioventricular
filling time evaluated from pulsed Doppler analysis of
transmitral LV filling.
Echocardiographic protocol. We have previously reported
in detail on the three-dimensional echocardiographic and
TDI protocol (5–7). We have also established our coeffi-
cient of variation of TDI measures of velocities and asyn-
chrony to be 4% to 6% (5), comparable to values reported by
other investigators (9). Three-dimensional echocardio-
Abbreviations and Acronyms
CRT  cardiac resynchronization therapy
DLC  delayed longitudinal contraction
GSCA  global systolic contraction amplitude
LV  left ventricle/ventricular
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RV  right ventricle/ventricular
SR  strain rate
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TT  tissue tracking
Figure 1. Tissue Doppler image in the apical four-chamber view of a normal subject (upper left panel). (Right panel) The velocity profile during one
cardiac cycle obtained at the base of the interventricular septum. The solid lines mark the duration of systole (310 ms), and the arrow indicates the peak
systolic velocity (8 cm/s). The diastolic filling of the LV is reflected in the E-wave (E) and A-wave (A). (Lower left panel) Tissue tracking displays, in
color-coded format, the regional myocardial shortening (mm) in each segment, calculated automatically as the integral of the digitally stored velocity tracing
in systole in each segment.
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Figure 2. (A) Apical long-axis view in a patient with dilated cardiomyopathy and left bundle branch block. Solid lines mark the duration of systole (300
ms). The sample point is located at the base of the anteroseptal region. In this region, the peak velocity is 4 cm/s (arrow). (Lower left panel) Tissue tracking.
From the color coding, it appears that the majority of the posterior wall is gray, indicating either no or paradoxical motion (i.e., motion away from the apex
during systole). (B) The same patient as in part A, with the cursor positioned in the basal segment of the posterior wall. The interval between the solid
lines in the right panel represents the duration (180 ms) of delayed longitudinal contraction (DLC), with a peak velocity of 6 cm/s (arrow). The onset
of this DLC corresponds to the cessation of systole in the septum, as in part A, right panel. Tissue tracking (lower left panel) displays the extent of
myocardium (colored segments) with DLC (diastole, open mitral valve). Note that the remaining part of the LV is gray, indicating either no motion or
motion toward the base of the heart (relaxation). The strain rate is required to detect shortening or passive stretching.
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graphic reproducibility was previously reported in depth
(6,7). In brief, three-dimensional echocardiography and
TDI were performed before implantation of the pacemaker,
immediately after implantation and every six months after
implantation. One observer, who had no knowledge of the
clinical data of the patients, performed all three-
dimensional echocardiographic and TDI analyses.
Three-dimensional echocardiography was performed
during end-expiratory apnea within one breath hold, using
electrocardiogram-triggered co-axial rotation from the api-
cal window with 30° intervals between the scanning planes.
The resulting six digital cine loops were transferred to a
computer for off-line analysis (Echo-Pac Software, GE-
Vingmed Ultrasound, Horten, Norway). In each view, the
endocardial borders were drawn manually in end diastole
and end systole for LV volume measurement.
Tissue Doppler imaging was acquired as digital loops
during one heart beat in the apical four-chamber, two-
chamber and long-axis views (5). Analysis of regional peak
contraction velocities toward the apex and the duration of
contraction (Fig. 1, showing a normal subject) was per-
formed in each of 16 segments of the LV model of the
American Society of Echocardiography (12).
A TT image in systole was derived from the TDI loop in
each of the apical views (Fig. 1, lower left panel; Fig. 2A,
lower left panel). If DLC was present, another TT image
was recorded in diastole to visualize the extent of myocar-
dium with DLC (Fig. 2B, lower left panel). The number of
segments displaying DLC at the base of the LV (5) was
recorded and expressed as the percentage of the total
circumference of the LV base. Myocardial segments show-
ing motion toward the apex were explored with SR analysis.
Motion toward the apex after closure of the aortic valve was
only registered as DLC if negative SR documented that the
motion reflected true shortening. Figure 3 shows the SR
analysis.
Figure 4 shows the development in myocardial perfor-
mance, displayed as TT images obtained during long-term
follow-up in one patient. Again using the 16-segment LV
model, the average motion amplitude toward the apex in
systole was estimated for each segment, and averages were
calculated for the six segments at the LV base, six mid-
ventricular segments and four apical segments. The global
systolic contraction amplitude (GSCA) index was calculated
as the average amplitude of all 16 segments.
Statistical analysis. The paired Student t test was used for
comparison of three-dimensional echocardiographic and
TDI measurements at baseline and during CRT. The QRS
width and DLC extent were correlated to long-term im-
provement in LV performance by univariate linear regres-
sion analysis. In addition, linear regression analysis was used
for the evaluation of changes in GSCA and percent LV
Figure 3. The same patient as in Figure 2. One sample (yellow) is positioned at the base of the septum and another (green) is located in the posterior wall.
In each point, strain rate (SR) analysis is carried out in a range of 10 mm. The first solid line (right panel) represents the onset of a negative SR in the
septum (yellow line), indicating the onset of systolic shortening. The second solid line indicates cessation of systole, where the SR in the septum becomes
positive. At the same time, a negative SR is observed in the posterior wall (green line), and this persists between the second and third lines, documenting
shortening in early diastole (i.e., delayed longitudinal contraction).
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ejection fraction (LVEF) during follow-up. A value of p 
0.05 was considered statistically significant. Data are pre-
sented as the mean value  SD.
RESULTS
Five (20%) of the 25 patients died during follow-up, before
the first outpatient examination. All of the patients who
died had ischemic heart disease. The QRS duration (179 
23 ms) was comparable to that of the remaining study
group. However, these patients displayed only limited DLC
at the LV base (20  12% of the LV base circumference),
and their immediate response to CRT, in terms of improve-
ment in LVEF, was minor (20.1  6% to 21.9  7%). The
remaining 20 patients were followed for a mean period of
12.6 months (range 6 to 18 months). The pre-implantation
demographic and clinical variables of these patients are
given in Table 1.
Long-term follow-up. At the end of follow-up, significant
reductions in the LV end-diastolic volume and LV end-
systolic volume of 9.6  14% and 16.9  15%, respectively,
as compared with hospital discharge, were demonstrated (p
 0.01). This was associated with a significant increase in
LVEF of 21.7  18% (p  0.01) (Table 2).
By means of TT, it was documented that the average
motion amplitude toward the apex during systole improved
significantly throughout the entire LV (Table 2). Figure 4
demonstrates the use of TT to visualize changes in motion
amplitude toward the apex in systole. The calculated im-
provement in GSCA from hospital discharge to the latest
follow-up visit for each patient was significantly correlated
to the improvement in LVEF (r  0.83, p  0.01). The
Figure 4. The upper panels represent the three apical views in systole in a patient with idiopathic dilated cardiomyopathy before implantation of a
biventricular pacemaker. The majority of the lateral wall, anterior wall and posterior wall are gray, indicating a lack of systolic motion toward the apex. The
mechanical function of the interventricular septum and inferior walls is abnormal, with a higher motion amplitude in the segment adjacent to the apex
(arrows). The lower panels show corresponding views after one year of cardiac resynchronization therapy. At this time, systolic motion toward the apex
is present in the entire left ventricle. In addition, the reverse distribution of motion amplitude in the septum and inferior wall has been normalized, with
greater systolic performance at the base of the left ventricle.
Table 1. Baseline Clinical and Demographic Variables in
Survivors (n  20)
NYHA functional class (III/IV) 11/9
Etiology (IHD/IDC) 11/9
LBBB/RBBB 18/2
Pre-implantation QRS duration (ms) 189  23
Pre-implantation LVEF (%) 23.8  6
Pre-implantation LVEDV (ml/m2) 318  89
Pre-implantation LVESV (ml/m2) 246  80
Pre-implantation MS (LV base) (mm) 2.4  0.8
Pre-implantation MS (mid-ventricular LV) (mm) 1.0  0.8
Pre-implantation MS (apical LV) (mm) 0.4  0.5
DLC at LV base circumference (%) 51.4  19
Data are presented as the number of patients or mean value  SD.
DLC  delayed longitudinal contraction; IDC  idiopatic dilated cardiomyop-
athy; IHD  ischemic heart disease; LBBB  left bundle branch block; LV  left
ventricle or ventricular; LVEF  left ventricular ejection fraction; LVEDV  left
ventricular end-diastolic volume; LVESV  left ventricular end-systolic volume;
MS  myocardial shortening toward the apex during systole; NYHA  New York
Heart Association; RBBB  right bundle branch block.
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percentage of the LV base circumference displaying DLC
was reduced from 18.7  7% at discharge to 8.1  8% at
one year (p  0.05).
There was improvement in NYHA functional class, from
3.5  0.4 at baseline to 2.2  0.5 at the completion of
follow-up (p  0.01). No significant change in medication,
such as angiotensin-converting enzyme inhibitors, diuretics,
or beta-blockers, was performed during follow-up.
Predictors of long-term efficacy. The percentage of the
LV base circumference exhibiting DLC, as measured at
baseline, predicted long-term improvement in LVEF and
GSCA (t  3.1, p  0.01 and t  3.3, p  0.01,
respectively) (Fig. 5). The QRS width did not predict
long-term CRT improvement in LVEF and GSCA (t 
1.0, p  NS and t  1.7, p  NS, respectively).
DISCUSSION
Cardiac resynchronization therapy appears to be a promis-
ing therapeutic option in patients with bundle branch block
and severe heart failure. In this study, we documented
long-term improvement in LV systolic performance and a
parallel reduction in LV volumes (i.e., reversed LV remod-
eling). The latter effect may be of particular interest, as it
might be associated with an improved prognosis in patients
with ischemic cardiomyopathy, where LV dilation has
emerged as a powerful predictor of mortality (13). In
patients with idiopathic dilated cardiomyopathy, however,
the prognostic determinants may seem more complex, but
the presence of a recruitable LV contractile reserve seems to
predict a more favorable outcome (14). However, the
potential impact of CRT on mortality awaits larger random-
ized trials.
Potential mechanisms underlying CRT benefit. Several
mechanisms could underlie the benefit of CRT on LV
function and remodeling. If LV wall stress fails to decline
during systole due to ailing LV systolic function, overall LV
wall stress will be persistently elevated, causing progressive
remodeling of the LV with continuous dilation. Therefore,
by improving global systolic LV function, long-term CRT
may reduce LV wall stress, a reduction that may, in turn,
contribute to reversed LV remodeling. In addition, DLC
(i.e., contraction during diastole representing mechanical
LV asynchrony) not only reflects a loss of systolic force, it
also causes inappropriate energy consumption and increased
LV wall stress in early diastole. This would presumably
interfere with regional myocardial perfusion that could, in
turn, further reduce LV systolic performance and aggravate
remodeling. Moreover, because CRT reduces the number of
segments displaying DLC, pacing not only improves sys-
tolic function by recruiting this contractile reserve, it also
facilitates diastolic filling of the LV. Interestingly, the
improvement in LV systolic performance during CRT is not
accompanied by an increase in myocardial oxygen consump-
Table 2. Left Ventricular Volumes and Regional Myocardial






LVEDV (ml) 289  92 261  94*
LVESV (ml) 206  74 171  75*
LVEF (%) 28.7  7 34.9  8*
MS at LV base (mm) 3.4  0.8 5.4  0.9*
MS at mid-ventricular LV (mm) 1.4  0.7 2.6  1.0*
MS at apical LV (mm) 0.5  0.6 1.0  0.8†
*p  0.01; †p  0.05. Data are presented as the mean value  SD.
CRT  cardiac resynchronization therapy; other abbreviations as in Table 1.
Figure 5. (Left) Scatterplot showing the relationship between the percentage of the left ventricular (LV) base circumference exhibiting delayed longitudinal
contraction (DLC) (x axis) and the percent change in global systolic contraction amplitude (GSCA) during follow-up. (Right) Scatterplot showing the
relationship between the percentage of the LV base circumference exhibiting DLC (x axis) and the percent change in left ventricular ejection fraction
(LVEF) during follow-up.
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tion (15), presumably because the reversion of LV remod-
eling, as documented in the present study, reduces myocar-
dial oxygen demand. Finally, the majority of patients with
end-stage heart failure and bundle branch block have
secondary mitral valve regurgitation. Thus, reduced mitral
regurgitation during CRT (16) could also contribute to the
observed reversed LV remodeling.
During short-term CRT, both LV volumes and systolic
function improve acutely (5,16). In our study of the
immediate-term effect of CRT, the improvement in systolic
function appeared to be confined to the base of the LV,
whereas the mid-ventricular and apical areas of the ventricle
did not seem to be resynchronized (5). We therefore
proposed the hypothesis that multiple LV leads might be
required to obtain resynchronization of more extended
regions of the LV (5). However, during long-term CRT,
both the mid-ventricular and the more distal part of the LV
eventually showed improved systolic performance (Table 2).
The absolute improvement in LVEF from baseline of the 20
patients was 11% (23.8% to 34.9%) before implantation to
one-year follow-up. The long-term effect of CRT after
hospital discharge was responsible for more than 50% of the
total increase in LVEF (Tables 1 and 2). Thus far, two
ventricular leads appear to be sufficient, although resynchro-
nization of the mid and apical parts of the LV seems to be
a delayed phenomenon.
Selection of responders to CRT. Our observation of
improvement in LV performance corresponds with the
recently published Multisite Stimulation in Cardiomyopa-
thies trial (MUSIC) showing a benefit of NYHA functional
class and physical endurance (17). In that study, patient
inclusion was based on a QRS duration above 150 ms, and
previous studies have emphasized the predictive value of the
QRS duration in relation to an improvement in LV function
during CRT (18). Our data, however, do not support the
use of the QRS duration as the primary selection criterion.
Indeed, it appears that the detection of mechanical asyn-
chrony, as reflected by DLC, is a superior predictor of CRT
efficacy. This is further supported by the observations in
patients who died during follow-up. These patients had
QRS widths comparable to those of survivors, but they had
less extensive mechanical asynchrony (i.e., areas with DLC
that could potentially be resynchronized into systole).
Therefore, it seems that pre-implantation TDI screening
could improve on the selection of candidates prone to
benefit from CRT, a hypothesis that is currently being
tested in a substudy in the Cardiac Resynchronization in
Heart Failure study (CARE-HF) (19).
Echocardiography in the evaluation of CRT. In the
present study, we applied two new TDI modalities. One
advantage of TT is the “at-a-glance” visualization of the
extent of myocardium with DLC (Fig. 2B), although more
conventional TDI may also be useful (5). Tissue tracking
also facilitates the demonstration of improvement in re-
gional and global longitudinal contraction (Fig. 4), and it
was shown that the improvement in overall longitudinal
contraction reflected the improvement in LVEF. In patients
with bundle branch block, the LV commonly exhibits
awkward rocking throughout the heart cycle, and it is often
impossible to decide whether motion reflects fiber shorten-
ing or merely passive stretching. In this setting, SR analysis
(Fig. 3) is a valuable tool to document when DLC repre-
sents contraction and thus a potential contractile “reserve”
that could be resynchronized into systole.
The LVEF measurements by three-dimensional echocar-
diography show excellent reproducibility, and according to
our most recent studies, the patient group required in a
two-dimensional echocardiographic study should be four
times larger, equivalent to 80 patients, to achieve identical
statistical power (6).
Conclusions. Cardiac resynchronization therapy immedi-
ately improves LV function. However, according to three-
dimensional echocardiography, the gain is even greater on a
long-term (one-year) basis, when the improvement includes
reversion of LV remodeling. Tissue Doppler imaging seems
to add important pathophysiologic information on the
degree, location and reduction of mechanical LV asyn-
chrony during continuous biventricular pacing and on re-
gional and global LV function. Finally, TDI may result in
the better selection of potential responders to CRT.
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